Hemang Jani highlights the stability of diagnostic stocks like Dr Lal PathLabs. He also talks about the midcap stocks' stability and performance despite high debt. Metro Brands and VIP Industries have been underperforming despite a tourism boom. He cautions against Hyundai due to slow growth but sees potential in future market corrections.
from Economic Times https://ift.tt/LSUTJzE
from Economic Times https://ift.tt/LSUTJzE
Time to buy diagnostic stocks? This is what Hemang Jani has to say
![Time to buy diagnostic stocks? This is what Hemang Jani has to say]()
Reviewed by News Today
on
October 24, 2024
Rating:
No comments: